Literature DB >> 10074950

Generic substitution and optimal patient care.

J E Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10074950     DOI： 10.1001/archinte.159.5.429

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  7 in total

1.  Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans.

Authors:  Michael A Fischer; Jerry Avorn
Journal:  Health Serv Res       Date:  2003-08       Impact factor: 3.402

2.  Patients' attitudes towards and experiences of generic drug substitution in Norway.

Authors:  Inge Kjoenniksen; Morten Lindbaek; Anne Gerd Granas
Journal:  Pharm World Sci       Date:  2006-11-17

Review 3.  Pharmacy utilization and the Medicare Modernization Act.

Authors:  Vittorio Maio; Laura Pizzi; Adam R Roumm; Janice Clarke; Neil I Goldfarb; David B Nash; David Chess
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

4.  Association of income and prescription drug coverage with generic medication use among older adults with hypertension.

Authors:  Alex D Federman; Ethan A Halm; Carolyn Zhu; Tsivia Hochman; Albert L Siu
Journal:  Am J Manag Care       Date:  2006-10       Impact factor: 2.229

Review 5.  Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Authors:  Aaron S Kesselheim; Alexander S Misono; Joy L Lee; Margaret R Stedman; M Alan Brookhart; Niteesh K Choudhry; William H Shrank
Journal:  JAMA       Date:  2008-12-03       Impact factor: 56.272

Review 6.  A composite screening tool for medication reviews of outpatients: general issues with specific examples.

Authors:  Peter A G M De Smet; Wilma Denneboom; Cees Kramers; Richard Grol
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 7.  Repeat prescribing: scale, problems and quality management in ambulatory care patients.

Authors:  Peter A G M De Smet; Maaike Dautzenberg
Journal:  Drugs       Date:  2004       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.